Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 12, 2020

SELL
$121.19 - $165.49 $2.18 Million - $2.98 Million
-17,985 Closed
0 $0
Q2 2020

Aug 05, 2020

BUY
$104.21 - $156.44 $1.87 Million - $2.81 Million
17,985 New
17,985 $2.66 Million
Q1 2020

May 14, 2020

SELL
$93.12 - $133.99 $1.91 Million - $2.75 Million
-20,500 Closed
0 $0
Q4 2019

Feb 12, 2020

BUY
$74.51 - $124.23 $1.53 Million - $2.55 Million
20,500 New
20,500 $2.36 Million

Others Institutions Holding ALNY

About ALNYLAM PHARMACEUTICALS, INC.


  • Ticker ALNY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 123,028,000
  • Market Cap $31.3B
  • Description
  • Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...
More about ALNY
Track This Portfolio

Track Delta Investment Management, LLC Portfolio

Follow Delta Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Delta Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Delta Investment Management, LLC with notifications on news.